Abstract. Hemophilia A (HA) is an X-linked recessive hereditary disorder caused by defects in the coagulation factor VIII (FVIII) gene. In order to diagnose patients with presymptomatic HA and carriers, the present study conducted direct gene diagnosis for the common abnormalities in FVIII and subsequently performed indirect gene diagnosis for the other abnormalities in FVIII for Chinese HA pedigrees. Direct gene diagnosis was performed in 10 HA pedigrees using inverse shifting-polymerase chain reaction to detect intron 22 inversion (inv22), intron 22 deletion, intron 22 duplication and inv1 of FVIII. Pedigrees with no detected mutations were further analyzed using indirect genetic diagnosis (haplotype linkage analysis), where the genetic markers of FVIII included one variable number of tandem repeat, seven short tandem repeats and three restriction fragment length polymorphisms. The results of three pedigrees were taken as examples. Pedigree 1 underwent direct gene diagnosis, which demonstrated that the proband was inv22 distal pattern hemophiliac and the mother was an inv22 distal pattern carrier. The other two pedigrees were subjected to indirect gene diagnosis. In pedigree 2, the detection of DXS52, 13(CA) n, DXS9901(GT) n, intron (int)18, int19 and int22 confirmed the proband's baby brother was normal, the proband's maternal aunt was a carrier and her baby son was normal. Detection of DXS9901(GT)n, int18, int19 and int22 in pedigree 3 demonstrated that the proband's maternal grandmother was not a carrier. As the maternal grandfather was not affected by the disease, it was deduced that a mutation of FVIII occurred in the proband's mother. The combination of direct and indirect gene diagnoses provides reliable evidence for the use of genetic counseling in HA pedigrees, particularly for screening presymptomatic males and female carriers with normal offspring.
Introduction
Hemophilia A is a hemorrhagic disease occurred much more frequently in males than in females, since it is an X-linked recessive hereditary disorder caused by diverse mutations in the coagulation factor VIII (FVIII) gene that affects 1 in 5,000 male newborns (1) . Patients are primarily infused with FVIII products for hemorrhage prophylaxis and there is currently no radical cure. FVIII gene mapping to Xq28 is 186 kb long and consists of 26 exons and 25 introns (2) . A total of ~20% of HA cases have a genetic etiology of intron 22 inversion (inv22) in the FVIII gene (3), which can be detected via direct gene diagnosis. However, the majority of patients with HA harbor different FVIII mutations, of which there are >1,000 types, thus direct gene diagnosis is difficult to perform (4) . Consequently, linkage analysis using closely-linked genetic markers (extragenic and intragenic) of the FVIII gene, has emerged as a principal method for detecting carriers. Genetic diagnosis of HA carriers is one of the most effective ways to reduce the birth numbers of newborns with HA. Currently the most widely used markers are variable number of tandem repeats (VNTRs), short tandem repeats (STRs) and restriction fragment length polymorphisms (RFLP) (5) . However, the linkage analysis method has limitations as families lacking heterozygous genetic markers are not suitable for this type of analysis (5) . Recombination between the genetic marker and mutation locus may also lead to misdiagnosis (5) . Therefore, in the present study, direct diagnosis, using inverse shifting-polymerase chain reaction (IS-PCR) to detect inv22 and inv1, was performed in combination with indirect gene diagnosis methods, using 11 genetic marker loci of VNTR, STR and RFLP for haplotype linkage analysis, for the genetic diagnosis of HA. The aim of the present study is to provide reliable evidence for genetic counseling for HA Direct gene diagnosis. The present study developed the direct gene diagnosis methodology using IS-PCR to detect inv22 and inv1. In addition, supplementary experiments were performed to detect intron 22 deletion (del22) and intron 22 duplication (dup22) in order to avoid misdiagnosis for inv22. The following primers were used: For inv22, the ID, 1U, 2U and 3U primers were used; for del22 and dup22, the ED, 1U, 2U and 3U primers were used; and for inv1, the1-ID, 1-IU and 1-ED primers were used. The sequences of these 8 primers are listed in Table I (7) . The DNA samples were digested using BclI enzyme. The purified products were then ligated with T4 DNA ligase and purified. Finally, IS-PCR amplification (95˚C for 30 sec, 60˚C for 60 sec, 72˚C for 90 sec; 35 cycles) was performed. The products were run on a 1% agarose gel with ethidium bromide, and the image was reversed. The diagnoses were made based on the different fragment lengths of the IS-PCR products for FVIII, which are presented in Table II , and the experiments were repeated three times. Table IV , and the experiments were repeated three times.
Results
Direct gene diagnosis of HA pedigree 1. DNA samples from 10 probands were analyzed by IS-PCR in order to detect inv22. Only one proband (pedigree 1) harbored the inv22 mutation. Subsequently, supplementary experiments were performed to confirm that it was inv22 and not del22 or dup22. Electrophoresis of the IS-PCR products for inv22 revealed that the proband was a distal inv22 homozygote ( Fig. 2A) . The proband's mother was a distal inv22 heterozygote and the father was normal.
The results of electrophoresis of the IS-PCR products for del22 or dup22 revealed that neither the proband, nor the proband's mother or father had del22 or dup22 mutations (Fig. 2B ). In addition, IS-PCR was performed in order to detect inv1 in the other 9 probands; however, inv1 was not detected in any of these patients.
Indirect gene diagnosis of HA pedigree 2 and 3. In the present study, 11 genetic marker loci were used for linkage analysis of the other nine pedigrees without inv22 and inv1; there were ≥4 genetic marker loci that could provide effective information for each pedigree. As the different families had different effective genetic marker loci, the present study presents two pedigrees as examples to present the results of indirect gene diagnosis analysis in the present study. Pedigree 2. Detection of the 11 genetic marker loci for pedigree 2, identified six marker loci that were heterozygous and could provide effective linkage information, including one VNTR locus (DXS52), two STR loci [13(CA)n and Table I . Sequences of the primers used for inverse shifting-polymerase chain reaction. Table II . Diagnoses made based on the different fragment sizes of the inverse shifting-polymerase chain reaction products for the coagulation factor VIII gene. , int19 and int22) . The genogram and the electrophoretogram of the PCR products of pedigree 2 are presented in Fig. 3 .
The results of the DXS52, DXS9901(GT)n and 13(CA) n loci (Fig. 3B-D) demonstrated that the band of the proband (III1) was in the same position as the proband's mother's (II3) lower band, indicating that the X chromosome was pathogenic and the mother was a carrier. The band of the proband's baby brother (III2) was in the same position as the mother's upper band, indicating his X chromosome was normal. The pathogenic X chromosome of the proband's maternal aunt (II5) and the proband's mother was inherited from the proband's maternal grandmother (I2), and the normal X chromosome was inherited from the proband's maternal grandfather (I1). The proband's maternal grandmother and aunt were carriers, and the proband's maternal grandfather was normal. The band of the baby son of the proband's maternal aunt (III3) was in the same position as the upper band of the proband's maternal aunt (II5), indicating their X chromosome was normal. In addition, the number of STR repeats (detected via capillary electrophoresis) of DXS9901(GT) n and 13(CA)n loci in each sample is presented in Fig. 3C and D.
The consistency in the size of the enzyme-digested products of int18 (Fig. 3E), int19 (Fig. 3F) and int22 (Fig. 3G) loci indicated that the X chromosome of the proband (III1), the same as one of the mother's (II3) X chromosomes, was pathogenic and thus, the mother was a carrier. The X chromosome of the proband's baby brother (III2) was not pathogenic, indicating he was normal. One of the X chromosomes of the proband's maternal grandmother (I2) was pathogenic while the X chromosome of the proband's maternal grandfather (I1) was normal, demonstrating that the mother's pathogenic and normal X chromosome came from the proband's maternal grandmother and maternal grandfather, respectively. The proband's maternal grandmother was a carrier and the proband's maternal grandfather was normal. One of the proband's maternal aunt's (II5) chromosomes was pathogenic and inherited from the proband's maternal grandmother, while the other normal X chromosome was inherited from the proband's maternal grandfather. The proband's maternal aunt was a carrier. Since her son (III3) had no pathogenic X chromosome, he could be diagnosed as normal.
To conclude the results of pedigree 2, the pathogenic X chromosome of the proband was inherited from the proband's mother who was a carrier. The proband's baby brother was normal and therefore, has no risk of severe bleeding in the future. The proband's maternal grandmother was a carrier and the proband's maternal grandfather was normal. The proband's maternal aunt was a carrier, and her baby son was normal and, therefore, also has no risk of severe bleeding in the future.
Pedigree 3. Detection of 11 genetic marker loci for pedigree 3 identified four marker loci that were heterozygous and could provide effective linkage information, including one STR locus [DXS9901(GT)n] and three RFLP loci (int18, int19 and int22). The genogram and the electrophoretogram of the PCR products of pedigree 3 are presented in Fig. 4 .
The results of DXS9901(GT)n locus analysis revealed that the band of the proband (III3) was in the same position as the proband's mother's (II5) lower band, indicating that the X chromosome was pathogenic and the mother was a carrier (Fig. 4B) . One of the two bands of the proband's baby sister (III4) was from the mother (the pathogenic X chromosome) and the other band was from the father (II4; the normal X chromosome), indicating that the proband's baby sister was a carrier. There was only one band for the proband's maternal grandmother (I2), which was in the same position as the upper band (the normal X chromosome) of the proband's mother, indicating it was not pathogenic. In addition, the number of STR repeats (detected via capillary electrophoresis) of the DXS9901(GT)n locus was marked in Fig. 4B . The haplotype linkage analysis results of the DXS52, DXS9901(GT)n, 13(CA)n, int18, int19 and int22 genetic marker loci of pedigree 2. According to the mutation haplotype of III1 (proband; indicated by an arrow), the grey bar represents the haplotype with a mutation while the white bar represents the haplotype without a mutation, the numbers within the grey and white bars indicate fragment size (bp) from the PCR. White squares, normal males; black square with an arrow, proband; black square with a forward slash, deceased male patient; black/white circles, female carriers; A1, int18/BclI allele positive; A2, int18/BclI allele negative; B1, int19/HindIII allele positive; B2, int19/Hind III allele negative; C1, int22/XbalI allele positive; C2, int22/XbalI allele negative. Electrophoresis of PCR products for the (B) DXS52, (C) DXS9901 (GT)n, (D) 13(CA)n, (E) int18, ( The results of the int18 (Fig. 4C), int19 (Fig. 4D) or int22  (Fig. 4E ) loci analysis demonstrated that the X chromosome of the proband (III3) was the same as one of the mother's (II3), as the size of enzyme-digested products were the same. Therefore, this X chromosome was pathogenic and the mother was a carrier. The pathogenic X chromosome of the proband's baby sister (III4) was inherited from the mother and the normal X chromosome was from the father (II4). Therefore, the baby sister was a carrier. The two X chromosomes of the proband's maternal grandmother (I2) were not pathogenic, therefore, the proband's maternal grandmother was normal.
To conclude the results of pedigree 3, the proband's maternal grandmother was normal and the pathogenic X chromosome of the proband was inherited from the proband's maternal grandfather. As the proband's grandfather was not diagnosed with HA, it is possible that a mutation of the FVIII gene occurred in the germ cell of the maternal grandfather, which was passed on to the mother. As with the proband's mother, the baby sister of the proband was also a carrier, and therefore, if she were to have sons they would be at risk of HA. However, the X chromosomes of the proband's maternal uncle and aunts, though inherited from the maternal grandfather, did not have the same mutant as the proband's mother, indicating that the maternal aunts and their female offspring were not carriers. The maternal uncle was normal.
Discussion
A total of ~40% of severe cases of HA have a genetic etiology of inv22 of the FVIII gene (12) , whereas inv1 is present in only 2-5% of severe cases (13, 14) . Hence, a direct method should be performed first to detect inversion mutations for patients with severe HA. Long distance PCR was once advocated to detect inv22; however, its limitations, including difficulties in amplification, a stringent requirement for template quality and poor repeatability, make it less reliable (15) . In recent years, investigators began to use inversion PCR (I-PCR), which consists of enzyme digestion, T4 ligase connection and PCR amplification. The advantages of I-PCR include lower quality requirement for templates, shorter DNA fragments to be amplified, good repeatability, an easy protocol and simple interpretation of the results (15) . This research adopted the IS-PCR method (7), which was the result of optimization and improvements made to the I-PCR protocol. IS-PCR can detect either inv22 or inv1, and homozygous patients or heterozygous carriers, it can distinguish inv22 distal inversion with proximal inversion, and it can eliminate the possibility of misdiagnosing del22 or dup22 as inv22. Previous studies including the use of the IS-PCR method for detecting HA have been infrequent until recently, and IS-PCR may be widely applied in clinical direct gene diagnosis for HA (16) .
The FVIII gene is associated with significant genetic heterogeneity, a large structure and complex alterations to molecular pathology, thus, current molecular biology methods have not been able to uncover all of the molecular defects (2). This renders the direct gene diagnosis of HA challenging (in all cases except for inv22). Consequently, the use of genetic markers inside or nearby the FVIII gene for indirect genetic diagnosis has become one of the main methods for HA gene diagnosis (17) .
Indirect genetic diagnosis for HA generally uses genetic markers, including VNTR, STR and RFLP, for linkage analysis. The commonly-used extragenic VNTR or STR loci include DXS52 (18, 19) , DXS15(CA)n (18,20), DXS9901(GT)n and DXS1073(GT)n (10). Intragenic STR loci include 13 (CA)n (11, 21, 22 ) and 22(GT)n(AG)n (21, 22) . Intragenic RFLP loci include BclI (23, 24) , HindIII (23, 24) , XbalI (23) and BglI (18) enzyme cutting loci in introns 18, 19, 22 and 25, respectively. Genetic markers used for linkage analysis should have a certain rate of heterozygosis (usually at least 30%) and should provide sufficient polymorphism information in a certain population. In general, in accordance with the heterozygous rate of the local population, genetic markers with a high heterozygous rate should be selected, and the combine use of several genetic markers may improve the efficiency of diagnosis. According to a previous report, the heterozygous rate of the RFLP loci int18, int19 and int22 in the north Indian population was 57, 38 and 43%, respectively (23) . The heterozygous rate of the STR loci in the Chinese population have been reported to be 34.6% (11) or 37.9% (22) for intron 1 (GT)n, 60.9% (25) or 61.0% (11, 22) for 13(CA)n, 43.6% (11) for 22(GT)n(AG)n and 38.2% (11) for 24(GT)n, respectively. The heterozygous rate of extragenic genetic markers of the STR loci DXS15(CA)n, DXS9901(GT)n and DXS1073(GT)n in the Chinese population have been reported to be 88.24 (10), 82.35 (10) and 62.0% (25) , respectively. Therefore, the present study applied these 11 genetic marker loci with high heterozygous rates for indirect genetic diagnosis in Chinese pedigrees. As there is a 3% recombination possibility within the large HA gene during meiosis (10), the present study used multiple heterozygous loci for haplotype linkage analysis in order to avoid incorrect linkage analysis as result of recombination between the genetic marker locus and the mutation locus.
In conclusion, the results of the present study may have academic and clinical implications. Linkage analysis could be used to diagnose affected pedigree members other than the proband, particularly presymptomatic males who would suffer from severe bleeding following trauma. Linkage analysis could also be used to accurately diagnose female carriers from potential female carriers. On this basis, linkage analysis could be applied for prenatal diagnosis in the male infants of female carriers, including all accurately diagnosed female carriers within the pedigree, not just the patient's mother. The results of the present study indicated that the combination of direct and indirect gene diagnosis may provide reliable evidence for the use of genetic counseling for HA pedigrees, particularly for screening presymptomatic males and female carriers with normal or no offspring, which may facilitate earlier treatments and disease prevention.
